Special Issue "Therapy Monitoring Based on PET Imaging"
A special issue of Tomography (ISSN 2379-139X).
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 4569
Special Issue Editor
Interests: cell therapy; cell tracking; molecular imaging; pulmonary inflammation; sepsis; immuno-PET; drug delivery
Special Issue Information
Dear Colleagues,
Positron emission tomography (PET) is a powerful technique for studying biological processes in vivo and is widely used in clinical settings to detect and diagnose diseases. In addition to diagnosis, PET can also be used to monitor therapy and study drug delivery, often providing signs of response earlier than morphological imaging techniques or than the appearance of clinical symptoms. This has largely been driven by the application of [18F]FDG-PET in oncology, but there are increasing examples of therapy monitoring by PET in infectious, inflammatory, neurological and other diseases. Many questions remain, such as the optimal timeframe for therapy monitoring, the best parameters to measure, and the utility of radiotracers targeting other metabolic pathways or, more specifically, the biological mechanisms underpinning each therapy. Recent years have also seen impressive developments in immunomodulatory therapies and adoptive cell therapies, whose patterns of response are unconventional and for which standard response criteria are not always adequate. Thus, there is a need to develop novel imaging tools to accurately monitor these therapies.
For this Special Issue, we invite investigators to contribute original research articles and reviews covering preclinical, translational and clinical studies using PET imaging to specifically monitor responses to therapy, in all types of disease. We encourage submissions covering the application of novel and established radiotracers to preclinical therapy models, PET imaging of cell therapies, theranostics and PET-guided drug delivery. We also welcome submissions covering the refinement and development of imaging biomarkers, PET radiomics and standardization issues in therapy monitoring.
Dr. Francis Man
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tomography is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular imaging
- theranostics
- cell tracking
- immuno-PET
- radiomics
- therapy monitoring
- drug delivery